TSE:BE - Beleave Stock Price, News & Analysis

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Beleave Inc., together with its subsidiaries, cultivates, produces, and sells tetrahydrocannabinol and cannabidiol medical cannabis in Canada and Colombia. The company produces cannabis oils and extracts for medical purposes. It also operates a network of medical cannabis clinics under the Medi-Green banner. Beleave Inc. is headquartered in Hamilton, Canada.

Industry, Sector and Symbol

Stock Exchange TSE

Industry Medicinals & botanicals

Sub-IndustryCannabis

SectorMedical

Current SymbolTSE:BE

Previous Symbol

CUSIPN/A

CIKN/A

WebN/A

PhoneN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

EmployeesN/A

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableOptionable

Receive BE News and Ratings via Email

Sign-up to receive the latest news and ratings for BE and its competitors with MarketBeat's FREE daily newsletter.

Beleave (TSE:BE) Frequently Asked Questions

What is Beleave's stock symbol?

Beleave trades on the Toronto Stock Exchange (TSX) under the ticker symbol "BE."

Has Beleave been receiving favorable news coverage?

News coverage about BE stock has trended somewhat positive recently, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Beleave earned a daily sentiment score of 0.9 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Beleave.

Who are some of Beleave's key competitors?

Some companies that are related to Beleave include Actelion (ALIOF), Canopy Growth (CGC), Aurora Cannabis (ACB), STADA Arzneimittel (STDAF), Cronos Group (CRON), Tilray (TLRY), USANA Health Sciences (USNA), Sundial Growers (SNDL), Canopy Rivers (RIV), Chromadex (CDXC), Foamix Pharmaceuticals (FOMX), True Drinks (TRUU), Mediwound (MDWD), Natural Alternatives International (NAII) and Mannatech (MTEX).

What other stocks do shareholders of Beleave own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Beleave investors own include Aurora Cannabis (ACB), Enbridge (ENB), Cannabix Technologies (BLO), New Age Brands (NF), Canopy Growth (CGC), Canopy Growth (WEED), Liberty Health Sciences (LHS), Lexaria Bioscience (LXX), Supreme Cannabis (FIRE) and Zynerba Pharmaceuticals (ZYNE).

How do I buy shares of Beleave?

Shares of BE and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

MarketBeat Community Rating for Beleave (TSE BE)

Community Ranking:		3.2 out of 5 ( )
Outperform Votes:		71 (Vote Outperform)
Underperform Votes:		39 (Vote Underperform)
Total Votes:		110

MarketBeat's community ratings are surveys of what our community members think about Beleave and other stocks. Vote "Outperform" if you believe BE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BE will underperform the S&P 500 over the long term. You may vote once every thirty days.

This page was last updated on 9/16/2019 by MarketBeat.com Staff